Banco Bilbao Vizcaya Argentaria S.A. Has $26.03 Million Holdings in Intuitive Surgical, Inc. $ISRG

Banco Bilbao Vizcaya Argentaria S.A. lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,903 shares of the medical equipment provider’s stock after selling 2,071 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Intuitive Surgical were worth $26,031,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Norges Bank bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $2,856,987,000. J. Stern & Co. LLP boosted its position in shares of Intuitive Surgical by 18,504.6% during the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after purchasing an additional 2,115,814 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in Intuitive Surgical by 1,043.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock worth $760,124,000 after purchasing an additional 1,224,734 shares during the period. Polen Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $477,225,000. Finally, Assenagon Asset Management S.A. lifted its stake in Intuitive Surgical by 106.6% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after buying an additional 791,516 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the sale, the executive vice president owned 5,720 shares in the company, valued at $2,426,080.80. This represents a 6.54% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director owned 120 shares of the company’s stock, valued at approximately $55,620. This represents a 49.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 7,169 shares of company stock valued at $3,059,135. 0.60% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

ISRG stock opened at $402.18 on Thursday. The business has a 50-day simple moving average of $440.46 and a two-hundred day simple moving average of $492.22. The company has a market capitalization of $142.44 billion, a P/E ratio of 48.75, a price-to-earnings-growth ratio of 3.39 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $396.68 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.81 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ISRG. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. Jefferies Financial Group dropped their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research report on Wednesday, April 22nd. Evercore cut their target price on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research note on Monday, April 6th. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Finally, Bank of America cut their price objective on shares of Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $573.42.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.